CrushSCI.com
Journal Selection & Manuscript Polishing Services
Clinical and Translational Allergy journal cover Medicine
Back to journal directory

Review Cycle Records

Clinical and Translational Allergy

Wiley SCIE OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q2
107.1Average days
113.5Median days
13Fastest days
205Longest days
1242025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

113 days

Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils

AuthorsRomana Vantur; Marusa Rihar; Ana Koren; Matija Rijavec; Peter Kopac; Urska Bidovec-Stojkovic; Renato Erzen; Peter Korosec

Affiliations1. University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; 2. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

Source PDF DOI Publisher page
114 days

Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium

AuthorsCancan Qi; Judith M. Vonk; Diana A. van der Plaat; Maartje A. E. Nieuwenhuis; F. Nicole Dijk; Dylan Aïssi; Valérie Siroux; H. Marike Boezen; Cheng-jian Xu; Gerard H. Koppelman

Affiliations1. Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2. GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 4. University Grenoble Alpes, Inserm, CNRS, Team of environmental epidemiology applied to Reproduction and Respiratory health, IAB (Institute for Advanced Biosciences), Grenoble, France; 5. Research Group of Bioinformatics and Computational Genomics, CiiM, Centre for individualized infection medicine, A Joint Venture Between Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 6. Department of Gastroenterology, Hepatology and Endocrinology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands

Source PDF DOI Publisher page
158 days

A novel ELISA method to determine human MrgX2 in chronic urticaria

AuthorsYuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong He

Affiliations1. College of Pharmacy, Xi’an Jiaotong University, Xi’an, China

Source PDF DOI Publisher page
177 days

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

AuthorsA. Bédard; X. Basagaña; J. M. Anto; J. Garcia-Aymerich; P. Devillier; S. Arnavielhe; A. Bedbrook; G. L. Onorato; W. Czarlewski; R. Murray; R. Almeida; J. A. Fonseca; J. Correia da Sousa; E. Costa; M. Morais-Almeida; A. Todo-Bom; L. Cecchi; G. De Feo; M. Illario; E. Menditto; R. Monti; C. Stellato; M. T. Ventura; I. Annesi-Maesano; I. Bosse; J. F. Fontaine; N. Pham-Thi; M. Thibaudon; P. Schmid-Grendelmeier; F. Spertini; N. H. Chavannes; W. J. Fokkens; S. Reitsma; R. Dubakiene; R. Emuzyte; V. Kvedariene; A. Valiulis; P. Kuna; B. Samolinski; L. Klimek; R. Mösges; O. Pfaar; S. Shamai; R. E. Roller-Wirnsberger; P. V. Tomazic; D. Ryan; A. Sheikh; T. Haahtela; S. Toppila-Salmi; E. Valovirta; V. Cardona; J. Mullol; A. Valero; M. Makris; N. G. Papadopoulos; E. P. Prokopakis; F. Psarros; C. Bachert; P. W. Hellings; B. Pugin; C. Bindslev-Jensen; E. Eller; I. Kull; E. Melén; M. Wickman; G. De Vries; M. van Eerd; I. Agache; I. J. Ansotegui; S. Bosnic-Anticevich; A. A. Cruz; T. Casale; J. C. Ivancevich; D. E. Larenas-Linnemann; M. Sofiev; D. Wallace; S. Waserman; A. Yorgancioglu; D. Laune; J. Bousquet

Affiliations1. ISGlobal, Barcelona, Spain; 2. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 3. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 4. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5. UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; 6. KYomed INNOV, Montpellier, France; 7. CHU de Montpellier, Montpellier, France; 8. Medical Consulting Czarlewski, Levallois, France; 9. Research fellow, OPC, and Director, Cambridge, UK; 10. Medscript, Paraparaumu, New Zealand; 11. Faculdade de Medicina da Universidade do Porto, Lda Porto, Portugal; 12. MEDIDA, Lda, Porto, Portugal; 13. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; 14. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal; 15. Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 16. UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 17. Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal; 18. Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 19. SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; 20. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 21. Division for Health Innovation, Campania Region, Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; 22. CIRFF, Federico II University, Naples, Italy; 23. Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino, Mauriziano Hospital, Turin, Italy; 24. Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; 25. Medical School Saint Antoine, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Paris, France; 26. Allergist La Rochelle, La Rochelle, France; 27. Allergist, Reims, France; 28. Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France; 29. RNSA (Réseau National de Surveillance Aérobiologique), Brussieu, France; 30. Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 31. Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 32. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands; 33. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands; 34. Clinic of Chest Diseases, Immunology and Allergology, Medical Faculty, Vilnius University, Vilnius, Lithuania; 35. Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 36. Department of Pathology, Faculty of Medicine and Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania; 37. Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; 38. European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium; 39. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 40. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; 41. Center for Rhinology and Allergology, Wiesbaden, Germany; 42. Medical Faculty, CRI-Clinical Research International-Ltd, Institute of Medical Statistics, and Computational Biology, University of Cologne, Hamburg, Germany; 43. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany; 44. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 45. Department of ENT, Medical University of Graz, Graz, Austria; 46. Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK; 47. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 48. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 49. Department of Lung Diseases and Clinical Immunology, University of Turku, Terveystalo Allergy Clinic, Turku, Finland; 50. Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, ARADyAL Research Network, Barcelona, Spain; 51. Rhinology Unit, & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; 52. Pneumology and Allergy Department CIBERES and Clinical, & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain; 53. Allergy Unit “D Kalogeromitros”, 2nd Dpt of Dermatology and Venereology, National & Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece; 54. Division of Infection, & Respiratory Medicine, Royal Manchester Children’s Hospital Immunity, University of Manchester, Manchester, UK; 55. Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P&A Kyriakou,” University of Athens, Athens, Greece; 56. Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece; 57. Allergy Department, Athens Naval Hospital, Athens, Greece; 58. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium; 59. Sun Yat-sen University, International Airway Research Center, Guangzou, China; 60. Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; 61. Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden; 62. Academic Medical Center, Univ of Amsterdam, Dept of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, The Netherlands; 63. European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 64. Odense University Hospital, Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; 65. Thermofisher Scientific, Uppsala, Sweden; 66. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach´s Children and Youth Hospital, Södersjukhuset, Sweden; 67. Sachs’ Children and Youth Hospital, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 68. Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 69. Peercode BV, Geldermalsen, The Netherlands; 70. Transylvania University Brasov, Brasov, Romania; 71. Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; 72. Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, Australia; 73. Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; 74. WHO GARD Planning Group, Salvador, Brazil; 75. Division of Allergy/Immunology, University of South Florida, Tampa, USA; 76. Clinica Santa Isabel, Servicio de Alergia e Immunologia, Buenos Aires, Argentina; 77. Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; 78. Finnish Meteorological Institute (FMI), Helsinki, Finland; 79. Nova Southeastern University, Fort Lauderdale, USA; 80. Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Canada; 81. Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; 82. University Hospital, Montpellier, France; 83. INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; 84. Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France; 85. Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 86. Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany

Source PDF DOI Publisher page
130 days

A pragmatic randomized controlled trial to improve inhaler technique using mHealth

AuthorsAnna Vanoverschelde; Paulien van der Wel; Barbara Putman; Lies Lahousse

Affiliations1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium; 2. Department of Medicine and Department of Environmental Medicine, New York University School of Medicine, New York, USA

Source PDF DOI Publisher page
48 days

Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes

AuthorsGador Bogas; Cristobalina Mayorga; Ángela Martín-Serrano; Rubén Fernández-Santamaría; Isabel M. Jiménez-Sánchez; Adriana Ariza; Esther Barrionuevo; Teresa Posadas; María Salas; Tahía Diana Fernández; María José Torres; María Isabel Montañez

Affiliations1. Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain; 2. Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain; 3. Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain; 4. Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga, Málaga, Spain; 5. Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain

Source PDF DOI Publisher page
13 days

Highlights and recent developments in allergic diseases in EAACI journals (2019)

AuthorsJ. Bousquet; C. E. Grattan; C. A. Akdis; P. A. Eigenmann; K. Hoffmann-Sommergruber; I. Agache; M. Jutel

Affiliations1. MACVIA-France, Montpellier, France; 2. CHRU Arnaud de Villeneuve, Montpellier Cedex 5, France; 3. St John’s Institute of Dermatology, Guy’s Hospital, London, UK; 4. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland; 5. Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland; 6. Depart of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria; 7. Transylvania University Brasov, Brasov, Romania; 8. Department of Clinical Immunology, Wrocław Medical University, Wrocław, Poland; 9. ALL-MED Medical Research Institute, Wrocław, Poland

Source PDF DOI Publisher page
43 days

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

AuthorsJean Bousquet; Jean-Paul Cristol; Wienczyslawa Czarlewski; Josep M. Anto; Adrian Martineau; Tari Haahtela; Susana C. Fonseca; Guido Iaccarino; Hubert Blain; Alessandro Fiocchi; G. Walter Canonica; Joao A. Fonseca; Alain Vidal; Hak-Jong Choi; Hyun Ju Kim; Vincent Le Moing; Jacques Reynes; Aziz Sheikh; Cezmi A. Akdis; Torsten Zuberbier

Affiliations1. Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany; 2. University Hospital Montpellier, Montpellier, France; 3. MACVIA-France, Montpellier, France; 4. Laboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU, Montpellier, France; 5. Medical Consulting Czarlewski, Levallois, France; 6. MASK-Air, Montpellier, France; 7. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 8. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 9. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 10. ISGlobAL, Barcelona, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; 11. Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; 12. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 13. GreenUPorto - Sustainable Agrifood Production Research Centre, DGAOT, Faculty of Sciences, University of Porto, Vila do Conde, Portugal; 14. Department of Advanced Biomedical Sciences, Federico II University, Napoli, Italy; 15. Department of Geriatrics, Montpellier University Hospital, Montpellier, France; 16. Division of Allergy, Department of Pediatric Medicine, The Bambino Gesu Children’s Research Hospital Holy See, Rome, Italy; 17. Personalized Medicine Asthma and Allergy Clinic-Humanitas University & Research Hospital, IRCCS, Milano, Italy; 18. CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida,, Porto, Portugal; 19. World Business Council for Sustainable Development (WBCSD) Maison de la Paix, Geneva, Switzerland; 20. AgroParisTech-Paris Institute of Technology for Life, Food and Environmental Sciences, Paris, France; 21. Microbiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea; 22. SME Service Department, Strategy and Planning Division, World Institute of Kimchi, Gwangju, Korea; 23. Maladies Infectieuses et Tropicales, CHU, Montpellier, France; 24. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 25. Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland

Source PDF DOI Publisher page
70 days

IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut

AuthorsAnna M. Ehlers; Stefanie Rohwer; Henny G. Otten; Bettina Brix; Thuy-My Le; Waltraud Suer; André C. Knulst

Affiliations1. Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; 2. Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; 3. Euroimmun AG, Lübeck, Germany

Source PDF DOI Publisher page
205 days

Hereditary angioedema caused by a premature stop codon mutation in the SERPING1 gene

AuthorsYing-Yang Xu; Jian-Qing Gu; Yu-Xiang Zhi

Affiliations1. Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.